Get up to speed on herpes simplex virus (HSV-1/HSV-2) epidemiology, novel antibodies, vaccine development, and cure ...

A simultaneous webcast will be available in the Investors section of Replimune’s website at replimune.com. A replay will be available for 30 days following the conference.

People given the herpes medication valacyclovir actually experienced worse cognitive decline than those given a placebo.

Herpes simplex virus (HSV) is a common infection with two main types, HSV-1 and HSV-2, typically affecting the mouth or genitals. It spreads through d ...

Mass General Brigham researchers found that hyperphosphorylated tau, the main component of pathological tangles in Alzheimer’s disease, may have serve to help protect the brain from infection ...

A romantic relationship that started on Tinder led to a civil jury trial in Hennepin County District Court that ended with ...

Researchers at Mass General Brigham have modified a herpes simplex virus (HSV-1) that stimulates the immune system to attack glioblastoma cells.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the expansion of ...

ImmVira Group ("ImmVira" or the "Company") announced a poster presentation at the 26th Annual Meeting of the Society of Urologic Oncology (SUO 2025). The presentation featured the latest ...

Mass General Brigham researchers engineer a virus that destroys brain tumor cells while avoiding healthy brain tissue ...

The immunotherapies used to treat melanoma now include well-established drugs such as Keytruda (pembrolizumab) and Opdivo (nivolumab) and newer ones such as Amtagvi (lifileucel), which uses T cells ...

One of the main proteins that contributes to Alzheimer's disease is called phospho-tau (p-tau). When p-tau gets too many phosphate groups attached to ...